FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) submitted by Novartis Pharmaceuticals Corporation. The document confirms the approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant
• Kidney Transplant
• Liver Transplant

Drugs mentioned

• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

SUPPL AP for MYFORTIC (MYCOPHENOLIC ACID)